ROLE OF DENDRITIC CELLS IN REGULATING VACCINE- INDUCED IMMUNITY AGAINST Q FEVER
ROLE OF DENDRITIC CELLS IN REGULATING VACCINE- INDUCED IMMUNITY AGAINST Q FEVER
批准号:
10049108
负责人:
Guoquan Zhang
金额:
$12.48万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-15 至 2021-04-30
关键词:
AcuteAerosolsAnimalsAntigen-Presenting CellsBone MarrowCD4 Positive T LymphocytesCell Differentiation processCell MaintenanceCell MaturationCellsCellular ImmunityChronicChronic DiseaseCoculture TechniquesCoxiella burnetiiDataDendritic CellsDevelopmentDiseaseEnzyme-Linked Immunosorbent AssayFlow CytometryFormalinFrequenciesGenerationsGoalsGram-Negative BacteriaHealthHumanImmuneImmune responseImmunityImmunizeIndividualInfectionInterleukin-12LipopolysaccharidesMHC Class II GenesMajor Histocompatibility ComplexMeasurableMeasuresMediatingMusOrganismOutcomes ResearchPatternPeptidesPhasePlayPreventionProductionQ FeverRiskRoleT cell differentiationT cell responseT-LymphocyteT-Lymphocyte SubsetsTestingTransgenic MiceVaccinationVaccine ProductionVaccinesVariantVirulentZoonosescytokinedesignfluin vivomouse modelnovelpathogenic microbeside effectvaccine-induced immunity
中文摘要
摘要
贝氏柯克斯体是一种专性细胞内革兰氏阴性细菌,可引起急性和慢性Q热,
人类迫切需要创造一种安全有效的疫苗来预防人类Q热。
然而,疫苗诱导的抗C.贝氏自然感染仍不清楚。
该项目的长期目标是开发一种安全有效的Q热疫苗。的目标
这一应用是实现这一目标的关键一步,目的是了解树突状细胞(DC)在
调节疫苗诱导的抗Q热免疫,并确定哪种类型的T细胞反应更关键
疫苗诱导的保护性免疫为了实现这一目标,提出了两个具体目标来测试
中心假设C.贝氏I期疫苗(PIV)和II期疫苗(PIIV)差异激活
DC,从而促进不同的T细胞应答,是它们赋予免疫应答能力差异的原因。
保护目的1将确定DC在调节疫苗诱导的抗Q热免疫中的作用,
检查i)PIV和PIIV是否差异性地激活DC,从而促进不同的T细胞分化模式
在小鼠模型中;和ii)DC是否在疫苗诱导的针对C.贝氏气溶胶感染
in vivo.目的2探讨CD 4 + T细胞亚群在PIV诱导的抗C.
通过使用小鼠模型研究贝氏气溶胶感染,i)PIV和PIV诱导的T细胞应答
负责其赋予保护能力的差异;和ii)哪种CD 4+亚群T细胞应答
对PIV诱导的保护作用更为关键。作为本研究的成果,它将为
了解DC在调节T细胞介导的免疫中的作用,并确定T细胞
疫苗诱导的抗C.贝氏体感染预计这将使
对健康的重大积极影响,因为它将提供关键信息,为发展一个安全的
和有效的Q热疫苗
英文摘要
Abstract
Coxiella burnetii is an obligate intracellular Gram-negative bacterium that causes acute and chronic Q fever in
humans. There is an urgent need to create a safe and effective vaccine for prevention of human Q fever.
However, the mechanisms of vaccine-induced immunity against C. burnetii natural infection remain unclear.
The long-term goal of this project is to develop a safe and effective vaccine against Q fever. The objective of
this application, which is a critical step towards this goal, is to understand the role of dendritic cells (DCs) in
regulating vaccine-induced immunity against Q fever and identify which type of T cell response is more critical
for vaccine-induced protective immunity. To achieve this objective, two specific aims were proposed to test the
central hypothesis that C. burnetii phase I vaccine (PIV) and phase II vaccine (PIIV) differentially activate
DCs, thereby promoting distinct T cell responses are responsible for the difference in their ability to confer
protection. Aim 1 will determine the role of DCs in regulating vaccine-induced immunity against Q fever by
examining i) if PIV and PIIV differentially activate DCs, thereby promoting distinct T cell differentiation patterns
in a mouse model; and ii) if DCs play a role in vaccine-induced protection against C. burnetii aerosol infection
in vivo. Aim 2 will determine the role of CD4+ T cell subsets in PIV-induced protective immunity against C.
burnetii aerosol infection by using a mouse model to investigate i) if PIV- and PIIV-induced T cell responses
are responsible for the difference in their ability to confer protection; and ii) which CD4+ subset T cell response
is more critical for PIV-induced protection. As an outcome of this research, it will gain novel information for
understanding the role of DCs in regulating T cell-mediated immunity and determining the role of T cell
responses in vaccine-induced protective immunity against C. burnetii infection. This is expected to have
significant positive effects on publich health, because it will provide critical information for developing a safe
and effective vaccine against Q fever.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of B-1 Cell-Mediated Immunity Against Coxiella burnetii Infection
-
批准号:10155409
-
项目类别:
-
资助金额:$21.34万
-
财政年份:2020
-
负责人:Guoquan Zhang
-
依托单位:
IDENTIFY NOVEL NEUTRALIZATION-SENSITIVE EPITOPES OF COXIELLA BURNETII
-
批准号:10020119
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2019
-
负责人:Guoquan Zhang
-
依托单位:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
-
批准号:10207396
-
项目类别:
-
资助金额:$51.26万
-
财政年份:2018
-
负责人:Guoquan Zhang
-
依托单位:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
-
批准号:10005679
-
项目类别:
-
资助金额:$52.67万
-
财政年份:2018
-
负责人:Guoquan Zhang
-
依托单位:
Use of a Humanized Antibody against Intracellular Bacterial Pathogen
-
批准号:10003580
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2018
-
负责人:Guoquan Zhang
-
依托单位:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
-
批准号:9982219
-
项目类别:
-
资助金额:$52.05万
-
财政年份:2018
-
负责人:Guoquan Zhang
-
依托单位:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
-
批准号:9762833
-
项目类别:
-
资助金额:$1.03万
-
财政年份:2018
-
负责人:Guoquan Zhang
-
依托单位:
Development of O Antigen-based Vaccines Against Q Fever
-
批准号:8582500
-
项目类别:
-
资助金额:$37.46万
-
财政年份:2010
-
负责人:Guoquan Zhang
-
依托单位:
Development of O Antigen-based Vaccines Against Q Fever
-
批准号:8386914
-
项目类别:
-
资助金额:$35.01万
-
财政年份:2010
-
负责人:Guoquan Zhang
-
依托单位:
Development of O Antigen-based Vaccines Against Q Fever
-
批准号:8197349
-
项目类别:
-
资助金额:$37.36万
-
财政年份:2010
-
负责人:Guoquan Zhang
-
依托单位:
Development of O Antigen-based Vaccines Against Q Fever
-
批准号:8042033
-
项目类别:
-
资助金额:$37.34万
-
财政年份:2010
-
负责人:Guoquan Zhang
-
依托单位:
The Role of Antibody-Mediated Protective Immunity Against Q fever
-
批准号:7876866
-
项目类别:
-
资助金额:$18.01万
-
财政年份:2009
-
负责人:Guoquan Zhang
-
依托单位:
The Role of Antibody-Mediated Protective Immunity Against Q fever
-
批准号:7740026
-
项目类别:
-
资助金额:$21.46万
-
财政年份:2009
-
负责人:Guoquan Zhang
-
依托单位:
海外基金